The Bulgarian Drug Agency initiates PIC/S membership procedure
post-template-default,single,single-post,postid-1120,single-format-standard,bridge-core-3.1.7,cookies-not-set,qode-page-transition-enabled,ajax_fade,page_not_loaded,,qode-title-hidden,qode_grid_1300,footer_responsive_adv,qode-child-theme-ver-1.0.0,qode-theme-ver-30.4.2,qode-theme-bridge,wpb-js-composer js-comp-ver-7.6,vc_responsive

The Bulgarian Drug Agency initiates PIC/S membership procedure

The Bulgarian Drug Agency (BDA) announced that they will initiate the procedure to become a member of the Pharmaceutical Inspection Co-operation Scheme (PIC/S).

PIC/S is a non-binding, informal co-operative arrangement between Regulatory Authorities in the field of Good Manufacturing Practice (GMP) of medicinal products for human or veterinary use. PIC/S aims at harmonising inspection procedures worldwide by developing common standards in the field of GMP, by providing training opportunities to inspectors and by facilitating co-operation and networking between competent authorities. Currently, there are more than 50 PIC/S members worldwide.

Update August 2018: the BDA announced that the PIC/S membership application was lodged on August 16th, 2018.

Update July 1, 2023: BDA officially joined the PIC/S.